We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Clinical Laboratory Segment in China Is Thriving

By LabMedica International staff writers
Posted on 01 Jun 2009
Healthcare spending despite the global recession, expands the clinical lab market in China.

A report by Kalorama Information (Rockville, MD, USA), published in partnership with healthcare IVD market research firm McEvoy & Farmer (Seattle, WA, USA; http://mcevoyandfarmer.com) claims that China's economic growth is estimated by nongovernmental sources to be even higher than the government's official report of about 10%. More...
The country is urbanizing and modernizing and the greater levels of prosperity will enable citizens to seek improved health care and diagnostics.

The Kalorama report forecasts that IVD markets in China will grow to more than $1.5 billion in 2009, making it the world's sixth largest IVD market. The last few years have seen market growth of 15-20%. Approximately 575 new hospitals open in China each year and the government plans to open more than 20,000 health clinics.

In January 2009, China's State Council announced a new US$123 billion healthcare spending program to bring a minimum standard of medical insurance coverage to 90% of entire population. The plan also aims to upgrade hospitals and improve health centers in rural and remote areas. This will result in an increased demand for small instrument placements at thousands of clinics and health centers across the country. China is already the world's number two market for automated IVD instrumentation. Now a significant but completely new market for smaller, more robust instrumentation is emerging.

Kalorama Information is a provider of market research reports for diagnostics, pharmaceutics, medical devices, biotechnology and healthcare. McEvoy and Farmer focus on a single sector of the economy--the IVD marketplace. The company specializes in the emerging markets of Asia and Latin America.

Related Links:

Kalorama Information
McEvoy & Farmer



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.